Schlappe, B. A., Mueller, J. J., Zivanovic, O., Gardner, G. J., Roche, K. L., Sonoda, Y., . . . O’Cearbhaill, R. E. (2016). Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecol Oncol.

Schlappe, Brooke A., Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, and Roisin E. O’Cearbhaill. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.

Schlappe, Brooke A., et al. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.